Pharming Group (STU:PHGN)
€ 0.6275 -0.0855 (-11.99%) Market Cap: 465.01 Mil Enterprise Value: 430.69 Mil PE Ratio: 0 PB Ratio: 2.26 GF Score: 74/100

Q3 2022 Pharming Group NV Earnings Call Transcript

Oct 27, 2022 / 11:30AM GMT
Release Date Price: €0.883 (-8.45%)
Operator

Hello, and welcome to Pharming's 9 Months 2022 Results Call. My name is Lauren, and I will be coordinating your call today. (Operator Instructions)

I will now hand you over to our host, Dr. Sijmen de Vries, CEO, to begin. Dr. Sijmen, please go ahead.

Sijmen de Vries
Pharming Group N.V. - President, CEO & Executive Director

Thank you very much, Lauren. Good morning, ladies and gentlemen, or good afternoon. I'm very pleased to have you here at the 9 months '22 Results Call. And with me here is my colleagues Anurag Relan, our Chief Medical Officer; and Jeroen Wakkerman, our Chief Financial Officer.

And before we do that, of course, I would like to -- you to look at that forward-looking statement slides because this presentation may contain forward-looking statements that, of course, are based upon our current estimations and beliefs and expectations and as you know, things -- circumstances could change towards the future.

Okay. And having said that, I would like to switch to the next slide, where you see probably a picture of 3

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot